Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca and its global biologics research and development arm, MedImmune, said on Friday that the Japanese Ministry of Health, Labour…
AstraZeneca and Merck have announced that the Japanese Ministry of Health, Labour and Welfare has approved Lynparza (olaparib) tablets (300mg…
Sandoz, a Novartis division and the global leader in biosimilars, today announced a global partnership with Asia’s premier biopharmaceuticals company,…
STADA Arzneimittel AG is advancing the internationalization of its OTC brand business. On January 12, 2018, the company reached an…
West-Ward Pharmaceuticals, wholly-owned Hikma Pharmaceuticals’s US subsidiary has launched Ifosfamide Injection, 1g/20mL vials, the generic equivalent to Ifex.
CTI BioPharma is expecting $10 million milestone in February, 2018 from Teva, related to a milestone for U.S. Food and…
TxCell got an interest-free loan from Bpifrance, a French government agency, for the preclinical development of its most advanced CAR-Treg…
The FDA has set Novartis’s Kymriah suspension injection for patients who have relapsed or refractory diffuse large B-cell lymphona (DLBCL)…
Ipsen and Exelixis on Tuesday said that their phase 3 study of study of cabozantinib in patients with advanced liver…
Midatech Pharma will conduct a study of an investigational new drug for the treatment of the fatal childhood brain cancer…